Tech Company Financing Transactions
Melior Discovery Funding Round
Melior Discovery closed a $500 thousand funding round on 1/25/2005. Investors included BioAdvance Ventures.
Transaction Overview
Company Name
Announced On
1/25/2005
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Proceeds Purpose
BioAdvance funding will initiate the company's Indications
Discovery platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
860 Springdale Dr. 500
Exton, PA 19341
USA
Exton, PA 19341
USA
Phone
Website
Email Address
Overview
Melior Discovery is dedicated to uncovering new therapeutic applications for partners' existing drugs. By utilizing the unique and highly efficient theraTRACESM indications discovery platform, Melior can systematically study a single compound in multiple in vivo models, thereby evaluating potential utility in a variety of major therapeutic areas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Reaume
Chief Operating Officer
Patty Ferrante
VP - Bus. Development
Ramana Kuchibhatla
VP - Operations
Amy DiCamillo
Browse more venture capital transactions:
Prev: 1/24/2005: Health Market Science venture capital transaction
Next: 1/25/2005: Predix Pharmaceuticals Holdings venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs